NLRP3 Inhibition Leads to Impaired Mucosal Fibroblast Function in Patients with Inflammatory Bowel Diseases

Inhibition of NLRP3 caused significantly reduced proliferation of intestinal fibroblasts from inflammatory bowel diseases patients, which was associated with a marked decrease in production of collagen type I and type VI.